ACUTE LEUKEMIAS
Clinical trials for ACUTE LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Tough-to-Treat leukemias
Disease control Recruiting nowThis early-stage study is testing a new drug called bleximenib in people with acute leukemia that has come back or not responded to other treatments. The first goal is to find a safe and effective dose. The second goal is to see if this dose can help patients achieve remission, w…
Matched conditions: ACUTE LEUKEMIAS
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists use radioactive tracer to follow leukemia Drug's journey through the body
Knowledge-focused Recruiting nowThis early-stage study aims to understand how the body absorbs, breaks down, and eliminates the experimental drug bleximenib in people with acute leukemia. Researchers will give a small, traceable radioactive version of the drug to 10 participants with specific types of advanced …
Matched conditions: ACUTE LEUKEMIAS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC